EGFR signaling contributes to acquired resistance to CDK4/6 inhibitors in ER plus breast cancer cells in vitro and in vivo

被引：0
|
作者：
Lypova, Nadiia
Lanceta, Lilibeth
Daugherty, Susan
Chesney, Jason
Imbert-Fernandez, Yoannis
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-13-18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-13-18
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combined inhibition of CDK2 and CDK4/6 overcomes acquired resistance to CDK4/6 inhibitors in breast cancer via RB-independent pathway
    Pandey, Kamal
    CANCER RESEARCH, 2020, 80 (16)
  • [32] The Role of CDK4/6 Inhibitors in Breast Cancer
    Murphy, Conleth G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (06)
  • [33] Update on CDK4/6 Inhibitors in Breast Cancer
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 298 - 300
  • [34] The Role of CDK4/6 Inhibitors in Breast Cancer
    Conleth G. Murphy
    Current Treatment Options in Oncology, 2019, 20
  • [35] CDK4/6 inhibitors in luminal breast cancer
    Gnant, Michael
    Steger, Guenther G.
    Bartsch, Rupert
    LANCET ONCOLOGY, 2015, 16 (01): : 2 - 3
  • [36] The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
    Gomes, Ines
    Abreu, Catarina
    Costa, Luis
    Casimiro, Sandra
    CANCERS, 2023, 15 (19)
  • [37] Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
    Pandey, Kamal
    An, Hee-Jung
    Kim, Seung Ki
    Lee, Seung Ah
    Kim, Sewha
    Lim, Sun Min
    Kim, Gun Min
    Sohn, Joohyuk
    Moon, Yong Wha
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) : 1179 - 1188
  • [38] DNA replication licensing is associated with resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Nanda, Sarmistha
    Shea, Martin J.
    Schiff, Rachel
    Osborne, C. Kent
    Rimawi, Mothaffar
    Fu, Xiaoyong
    CANCER RESEARCH, 2023, 83 (05)
  • [39] 6-Phosphofructo-2-kinase inhibition to increase the efficacy of ER and CDK4/6 inhibitors against ER plus breast cancer
    Lanceta, Lilibeth
    Lypova, Nadiia
    Chesney, Jasson
    Imbert-Fernandez, Yoannis
    CANCER RESEARCH, 2020, 80 (16)
  • [40] Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
    Portman, Neil
    Alexandrou, Sarah
    Carson, Emma
    Wang, Shudong
    Lim, Elgene
    Caldon, C. Elizabeth
    ENDOCRINE-RELATED CANCER, 2019, 26 (01) : R15 - R30
12345